Download Docs
Export

TETRAVECTA

98432248 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed March 4, 2024
Serial No. 98432248
Examining Attorney ANDREA KOYNER NADELMAN
Class Custom manufacture of products relating to biotechnology, namely, custom manufacture of biopharmaceuticals for use in cell and gene therapies; custom manufacture of gene and cell-based therapy products, namely, genetically engineered cells and tissues for cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of biopharmaceuticals used in cell and gene therapies, and biopharmaceutical preparations; biotechnology contract manufacturing services, namely, contract manufacturing in the field of pharmaceuticals and biopharmaceuticals for cell and gene therapy using biological organisms in the manufacturing process; contract manufacturing services of gene and cell-based therapy products, namely, biopharmaceuticals for cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of biopharmaceuticals for cell and gene therapies and biopharmaceutical products, namely, biopharmaceuticals for cell and gene therapies; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products, namely, custom manufacture of biopharmaceuticals for cell and gene therapies; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations, namely, custom manufacture of pharmaceuticals and biopharmaceuticals for cell and gene therapies; 100; 103; 106; 100; 101
TETRAVECTA
Case Type Service mark
Status An Office action suspending further action on the application has been sent (issued) to the applicant. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 2 weeks, 1 day ago
Filing Date # Docket Text
to view the full docket.